Binding Agreement to Acquire Substantially All NanoString Assets for $220 Million Pending Bankruptcy Court Approval Agreement Represents Major Step in Financial Restructuring and Provides Continuity for Customers and Employees SEATTLE — NanoString Technologies, Inc. (OTC: NSTGQ) (“NanoString” or the “Company”), a leading provider of life science tools for discovery and translational research, today announced that it has […]

Cambridge, Mass. – Vizgen, Inc., the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, has announced a significant capital raise to fuel its continued growth and execution of long-term vision. At the same time, the company has also taken steps to streamline its operations and reduce headcount. These measures […]

BOHEMIA, NY — Scientific Industries, Inc. (“SI”) (OTCQB:SCND) announced the appointment of John Nicols to the Board of Directors of SI and Chairman of its wholly, owned subsidiary, Scientific Bioprocessing Inc. (“SBI”), effective March 4, 2024. Mr. Nicols replaces Mr. John A. Moore as Chairman of SBI. John A. Moore, Chairman of SI, said “We are […]

FREMONT, Calif. — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, announced today that it has opened a new 50,000-square-foot facility in Wuxi, China. This strategic move increases the company’s manufacturing capacity to meet the growing worldwide demand for comprehensive cell analysis solutions. The Wuxi facility offers the advantage of fostering unique vendor […]

bit.bio announces first project within multi-year collaboration agreement with The Michael J. Fox Foundation (MJFF) to generate human cell products for research and drug discovery in Parkinson’s disease First project will prioritise the discovery and development of a key human cell type for Parkinson’s disease (PD) research and drug discovery. Collaboration agreement allows MJFF to […]

NEWARK, Calif. — ACROBiosystems, one of the leading providers of innovative tools and solutions used from discovery to the clinic, has announced a new corporate initiative to support ex vivo cell manufacturing and manufacturers of innovative cell and gene therapies. In response to the shifting landscape of biologics manufacturing across the globe, this initiative is designed to […]

Wetzlar, Germany – Leica Microsystems, a leader in microscopy and scientific instrumentation, has revealed TauSTED Xtend, a new STED microscopy approach that enables extended multicolor live cell imaging at nanoscopic resolution. By combining spatial and lifetime information, TauSTED Xtend resolves details of live or intact specimens at nanoscale. At the same time, the access to […]

BILLERICA, Massachusetts ─  Bruker today announced that it has completed the acquisition of Phasefocus Holdings Limited, which was already announced on December 22nd, 2023. Phasefocus is a privately held company that has leading expertise in imaging and image processing algorithms. Phasefocus has deployed their expertise to develop a novel optical microscope, called Livecyte, for label […]

Major asset acquisition from a U.S.-based company marks another milestone for Canada’s largest biotechnology company Vancouver, BC – STEMCELL Technologies is pleased to announce the acquisition of substantially all assets of SQZ Biotechnologies Company (SQZ)—a Massachusetts-based biotech known for its game-changing method of introducing a variety of therapeutic cargo into cells by squeezing them (mechanoporation) rather […]

BOSTON & SOUTH SAN FRANCISCO, Calif. — 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, and Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and commercial-scale cell therapy manufacturing, announce a development collaboration to integrate in-line monitoring of key cell culture parameters into […]